Moneycontrol
Get App
SENSEX NIFTY
you are here:

Parabolic Drugs Ltd.

BSE: 533211 | NSE: PARABDRUGS |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.
Series: BE | ISIN: INE618H01016 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 17, 16:00
2.61 -0.13 (-4.74%)
Volume
AVERAGE VOLUME
5-Day
1,591
10-Day
8,166
30-Day
22,250
301
  • Prev. Close

    2.74

  • Open Price

    2.61

2.61

Today’s L/H

2.61
0.59

52 Wk L/H

4.73
2.61

L/U Price Band

2.87
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    2.61
     Beta
    0.43
  • Market Depth (17 Jan 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    0 0.00 2.61 122599
    0 0.00 2.74 5100
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Jan 17, 15:32
1.80 -0.05 (-2.70%)
Volume
AVERAGE VOLUME
5-Day
5,418
10-Day
4,025
30-Day
17,350
18,087
  • Prev. Close

    1.85

  • Open Price

    1.80

1.80

Today’s L/H

1.80
0.45

52 Wk L/H

4.05
1.80

L/U Price Band

1.90
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    1.80
     Beta
    0.00
  • DELIVERY AVERAGES
    3-Day
    70.33%
    5-Day
    86.46%
    8-Day
    86.96%
    Deliverables
  • SMA VOLUME
    30
    2.83
    50
    2.42
    150
    1.39
    200
    1.40
    SMA
    2.83

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
bearish
Moving Averages Bearish
Technical Indicators Bearish
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 1.80 1.80 1.80 1.80 1.80 1.80 1.80
Fibonacci 1.80 1.80 1.80 1.80 1.80 1.80 1.80
Camarilla 1.80 1.80 1.80 1.80 1.80 1.80 1.80

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 1.91
10 2.13
20 2.68
50 2.42
100 1.67
200 1.40
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Valuation

    • Market Cap (Rs Cr.)
      16.15
    • P/E
      -
    • Book Value (Rs)
      -143.31
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      30.87
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      70.33
      5-Day
      86.46
      8-Day
      86.96
      73.44

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      16.15
    • P/E
      -
    • Book Value (Rs)
      -142.40
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      30.87
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      70.33
      5-Day
      86.46
      8-Day
      86.96
      73.44

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 3 investor views

BUY SELL HOLD

Action in Parabolic Drugs Ltd.

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 17, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 16, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 15, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 14, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 13, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 10, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 09, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 08, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 07, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 06, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 03, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 02, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Jan 01, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Dec 31, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Dec 30, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Dec 27, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Dec 26, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Dec 24, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on BSE

    Dec 23, 10:05

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Dec 20, 10:05

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Jun 2019 Mar 2019 Dec 2018 Sep 2018 Jun 2018
Net Sales -- -- 0.22 4.92 12.85
Other Income 0.01 0.01 0.01 0.66 0.13
PBDIT -1.95 -1.97 -2.01 -5.92 -4.86
Net Profit -7.49 -8.70 -7.09 -14.35 -10.52

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 61.89 61.89
Networth -886.99 -846.33
Total Debt 984.70 984.11
Net Block 304.40 326.37
Investments 6.34 6.34
Total Assets 97.71 137.78

On
Current Price %Gain / Loss
No Record Found
On
Current Price %Gain / Loss
No Record Found
to view the Open, High, Low, Close, Volume and Historic data for
Array

CORPORATE ACTION

Date Agenda
May 29, 2019 Audited Results
Type Dividend% Ex-Dividend date
Final 2.50 Sep 24, 2012
Final 5.00 Sep 19, 2011
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Parabolic Drugs
Old FV New FV Ex-Split
No Splits Information is available for Parabolic Drugs
Ratio Premium Ex-Bonus
No Rights Information is available for Parabolic Drugs
Date Agenda
- -
Sep 29, 2017 -
Sep 29, 2016 -
Sep 29, 2015 -
Sep 30, 2014 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 December 2018 September 2018 March 2018
Promoters 37.79 37.79 37.79 37.79
Pledged 96.71 96.71 96.71 96.71
FII/FPI 8.06 8.06 8.06 8.06
Total DII 12.19 12.54 12.62 13.7
Fin.Insts 0.57 0.57 0.57 0.57
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 11.62 11.97 12.05 13.13
Others 41.95 41.6 41.52 40.44
Total 99.99 99.99 99.99 99.99

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Parabolic Drugs 2.61 -4.74 4.73 0.59 16.15 18.08 -40.66
Sun Pharma 454.45 1.24 484.10 350.40 109037.78 10,303.21 816.60
Divis Labs 1903.45 0.22 1915.05 1460.55 50530.62 4,879.66 1,332.65
Dr Reddys Labs 3033.65 3.27 3049.05 2065.30 50407.53 10,625.50 1,277.30
Cipla 480.25 0.06 585.50 389.55 38719.08 12,374.01 1,888.41

COMPANY OVERVIEW

Parabolic Drugs Limited (PDL), founded in 1996, is engaged in the manufacture including contract manufacture of APIs and API intermediates. In the year 2011, the company has stepped up in the value chain by foraying into the domestic formulations. Today PDL has four large scale facilities, three state of the art manufacturing plants at Derabassi, Chachhrauli and Panchkula for over 50 API and API intermediates across antibiotics and non antibiotic therapies and a Custom Synthesis and R&D centre at Barwala, Haryana. The company is surging ahead with the right set of drivers backward and forward integration, world class infrastructure, R&D strengths, diversified product basket across different therapeutic segments and Intellectual Property Rights in the form of DMFs, and Patents for novel processes.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Pranav Gupta

      Managing Director

    • Vineet Gupta

      Whole Time Director

    • Sanjeev Kumar

      Director

    • Jagjit Singh Chahal

      Director

    • Vandana Singla

      Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Parabolic Drugs Ltd.

Parabolic Drugs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 533211 and the NSE with an NSE Code of PARABDRUGS.

Related Searches